Aprea Therapeutics Acquires Atrin Pharmaceuticals, Reports Q1
- ByInvesting.com-
Aprea Therapeutics, Inc. (Nasdaq: NASDAQ:APRE) today announced that it has acquired Atrin Pharmaceuticals Inc. and reported financial results for the three months ended March 31,...